Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluebird Mer Regulatory News (BMV)

Share Price Information for Bluebird Mer (BMV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.60
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.05 (8.333%)
Open: 0.625
High: 0.625
Low: 0.625
Prev. Close: 0.625
BMV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

South Korean Board Appointment

20 Jul 2022 07:00

RNS Number : 0934T
Bluebird Merchant Ventures Limited
20 July 2022
 

Bluebird Merchant Ventures Ltd

("Company" or "Bluebird")

South Korean Board Appointment

Bluebird Merchant Ventures (EPIC: BMV), the South Korean focused gold development group is pleased to announce the appointment of Mr. Sung Kwan (Daniel) Sun to the Board of Directors of the South Korean subsidiary companies. The Company considers this to be a key appointment that will strengthen the Company and its operations in South Korea. As the projects move into production there will be significantly more work taking place in country than previously and this requires experienced personnel in key positions.

Daniel Sun is a graduate of Sogang University. He worked at Deloitte Anjin LLC from 2004 to 2014. He is an advisor to the Korea Trade-Investment Promotion Agency (KONTRA) Global Mergers and Acquisitions. Daniel specialises in foreign invested Korean companies. He has successfully assisted Doosan Group, a South Korean multinational conglomerate in their overseas acquisitions of Mitsui Babcock (UK), Labmeyer (Germany) and Isola (USA). He also assisted in the management of offshore projects by Mirae Asset Real Estate Funds, Lotte Construction and Dongwon Group in the acquisition of Starkist. Daniel is also a Certified Public Accountant and a partner at Wooin Accounting Firm.

 

The Company has previously made announcements regarding the admission to trading of shares that were previously issued. After dialogue with the FCA, the Company has been able to determine a certain number of historical share issuances that require admission to trading. 

An application has been made for the Admission of the following shares to trading - 13,003,268 shares at an average of 2p ("Funding Shares"); the exercise of warrants over 2,692,307 shares at 1.3p ("Warrant Exercise Shares"); and 62,385,234 shares at an average of 2.49p ("April 2016 to March 2019 Shares"). The Company had believed that the April 2016 to March 2019 Shares had previously be admitted to trading as the Company published a Prospectus on 13 June 2019 and 20 December 2021. Admission is expected to occur on or around 21 July 2022. Upon Admission there will be 638,115,042 shares in issue.

Colin Patterson, CEO, commented:

"I am delighted to welcome Daniel to the team. I have been impressed with his professionalism and am confident that his appointment will contribute to the success of our Company. I am also expecting that we will be announcing further key appointments over time." 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 ("MAR").

Enquiries:

Bluebird Merchant Ventures Ltd

Jonathan Morley-Kirk, Non-Executive Chairman jmk@bluebirdmv.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGZNZGGGZZG
Date   Source Headline
3rd Oct 20229:05 amRNSSecond Price Monitoring Extn
3rd Oct 20229:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSUpdated Corporate Presentation
30th Sep 20227:00 amRNSInterim Financial Report 30 June 2022
29th Sep 20227:00 amRNSTR1 Notification
23rd Sep 20227:00 amRNSTR1 - Notification of major holdings
23rd Sep 20227:00 amRNSTR1 - Notification of major holdings
5th Sep 20227:00 amRNSBatangas Gold Project and South Korea Update
20th Jul 20227:00 amRNSSouth Korean Board Appointment
30th Jun 20227:00 amRNSAnnual Financial Report 31 December 2021
21st Jun 20227:00 amRNSOperational Update
16th Jun 20227:00 amRNSUpdated Research Coverage
1st Jun 20229:30 amRNSOperational Update
27th May 20224:40 pmRNSSecond Price Monitoring Extn
27th May 20224:35 pmRNSPrice Monitoring Extension
25th May 20227:00 amRNSBatangas Gold Project Update
23rd May 20229:30 amRNSSouth Korean Visit Strategy Update
17th May 20229:30 amRNSSouth Korea Visit Initial Report
26th Apr 20229:05 amRNSSecond Price Monitoring Extn
26th Apr 20229:00 amRNSPrice Monitoring Extension
26th Apr 20227:00 amRNSConfirmation Of First Loan Tranche Disbursement
19th Apr 20227:00 amRNSRe: Funding package to move to production
12th Apr 202210:30 amRNSFunding package to accelerate move to production
24th Feb 20227:00 amRNSOperational and Strategic Update
17th Feb 20227:00 amRNSNew Website
7th Jan 20224:41 pmRNSSecond Price Monitoring Extn
7th Jan 20224:36 pmRNSPrice Monitoring Extension
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
7th Jan 202211:06 amRNSSecond Price Monitoring Extn
7th Jan 202211:00 amRNSPrice Monitoring Extension
7th Jan 20229:05 amRNSSecond Price Monitoring Extn
7th Jan 20229:00 amRNSPrice Monitoring Extension
6th Jan 20227:00 amRNSAGM Results
23rd Dec 20217:00 amRNSAnnouncement of Admission of Shares
23rd Dec 20217:00 amRNSNotice of AGM
20th Dec 20217:00 amRNSPublication of a Prospectus and Issue of Equity
29th Oct 20212:00 pmRNSHalf Yearly Financial Report 30 June 2021
19th Jul 20217:00 amRNSOperational Update
8th Jul 20218:33 amRNSDirector/PDMR Shareholding
30th Jun 20211:48 pmRNSAnnual Financial Report 31 December 2020
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
29th Jun 202111:05 amRNSSecond Price Monitoring Extn
29th Jun 202111:00 amRNSPrice Monitoring Extension
29th Jun 20219:06 amRNSSecond Price Monitoring Extn
29th Jun 20219:00 amRNSPrice Monitoring Extension
29th Jun 20217:00 amRNSBluebird Acquires 100% of the South Korea Projects
30th Mar 20214:41 pmRNSSecond Price Monitoring Extn
30th Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.